chr4:55593613:T>A Detail (hg19) (KIT)
Information
Genome
Assembly | Position |
---|---|
hg19 | chr4:55,593,613-55,593,613 |
hg38 | chr4:54,727,447-54,727,447 View the variant detail on this assembly version. |
HGVS
Type | Transcript | Protein |
---|---|---|
RefSeq | NM_000222.2:c.1679T>A | NP_000213.1:p.Val560Asp |
NM_001093772.1:c.1670T>A | NP_001087241.1:p.Val557Asp | |
Ensemble | ENST00000288135.6:c.1679T>A | ENST00000288135.6:p.Val560Asp |
Summary
MGeND
Clinical significance |
![]() |
Variant entry | 2 |
GWAS entry | |
Disease area statistics | Show details |
Frequency
[No Data.]
Prediction
ClinVar
Clinical Significance |
![]() |
Review star | ![]() |
Show details |
Disease area statistics
MGeND
Clinical significance | Last evaluated | Condition | Origin | Submission ID | Submitter | Institute | Citation | Comment | Image |
---|---|---|---|---|---|---|---|---|---|
![]() |
other |
![]() |
MGS000039
(TMGS000092) |
Hitoshi Nakagama | National Cancer Center Japan |
29659903
|
|||
![]() |
small intestine, unspecified |
![]() |
MGS000042
(TMGS000093) |
Hitoshi Nakagama | National Cancer Center Japan |
ClinVar
Clinical significance | Last evaluated | Review status | Condition | Origin | Links |
---|---|---|---|---|---|
![]() |
2015-07-14 | no assertion criteria provided | melanoma |
![]() |
Detail |
![]() |
2016-05-13 | no assertion criteria provided | gastrointestinal stromal tumor |
![]() |
Detail |
![]() |
2024-02-23 | criteria provided, single submitter | Hereditary cancer-predisposing syndrome |
![]() |
Detail |
CIViC
Disease | Drug | EL | ET | ED | CS | VO | TR | Pubmed | Links |
---|---|---|---|---|---|---|---|---|---|
cancer | Sunitinib | D |
![]() |
![]() |
Resistance | Somatic | 2 | 18955458 | Detail |
gastrointestinal stromal tumor | Sunitinib | C |
![]() |
![]() |
Resistance | Somatic | 3 | 18955458 | Detail |
gastrointestinal stromal tumor | Sunitinib,Regorafenib,Ponatinib,Imatinib | D |
![]() |
![]() |
Sensitivity/Response | Somatic | 3 | 25239608 | Detail |
cancer | Imatinib Mesylate | D |
![]() |
![]() |
Sensitivity/Response | Somatic | 2 | 18955458 | Detail |
DisGeNET
Score | Disease name | Description | Source | Pubmed | Links |
---|---|---|---|---|---|
0.760 | Gastrointestinal Stromal Tumors | Previously, we found 2 types of gain-of-function mutation of the PDGFRA gene, Va... | BeFree | 15221957 | Detail |
0.616 | Gastrointestinal Stromal Tumors | Previously, we found 2 types of gain-of-function mutation of the PDGFRA gene, Va... | BeFree | 15221957 | Detail |
0.019 | urticaria pigmentosa | Distinct signalling pathways for mutated KIT(V560G) and KIT(D816V) in mastocytos... | BeFree | 23777495 | Detail |
0.118 | mastocytosis | Distinct signalling pathways for mutated KIT(V560G) and KIT(D816V) in mastocytos... | BeFree | 23777495 | Detail |
0.126 | Leukemia, Mast-Cell | Ponatinib was found to inhibit the kinase activity of KIT G560V and KIT D816V in... | BeFree | 23539538 | Detail |
0.019 | leukemia | Two subclones of the HMC1 mast leukaemia cell line were used; both express an id... | BeFree | 19804454 | Detail |
0.760 | Gastrointestinal Stromal Tumors | We expressed c-KIT cDNA constructs encoding the V654A substitution alone and in ... | BeFree | 17363509 | Detail |
Annotation
Annotations
Descrption | Source | Links |
---|---|---|
In an in vitro study, Chinese hamster ovary cells expressing KIT V560D demonstrated comparable sensi... | CIViC Evidence | Detail |
Patient 72 from a larger cohort of genotyped patients (n= 78) with imatinib resistant or intolerant ... | CIViC Evidence | Detail |
In an in vitro study, an IL3 independent Ba/F3 cell line expressing KIT V560D primary activating mut... | CIViC Evidence | Detail |
In an in vitro study, Chinese hamster ovary cells expressing KIT V560D mutation demonstrated sensiti... | CIViC Evidence | Detail |
NM_000222.3(KIT):c.1679T>A (p.Val560Asp) AND Melanoma | ClinVar | Detail |
NM_000222.3(KIT):c.1679T>A (p.Val560Asp) AND Gastrointestinal stromal tumor | ClinVar | Detail |
NM_000222.3(KIT):c.1679T>A (p.Val560Asp) AND Hereditary cancer-predisposing syndrome | ClinVar | Detail |
Previously, we found 2 types of gain-of-function mutation of the PDGFRA gene, Val561 to Asp and Asp8... | DisGeNET | Detail |
Previously, we found 2 types of gain-of-function mutation of the PDGFRA gene, Val561 to Asp and Asp8... | DisGeNET | Detail |
Distinct signalling pathways for mutated KIT(V560G) and KIT(D816V) in mastocytosis. | DisGeNET | Detail |
Distinct signalling pathways for mutated KIT(V560G) and KIT(D816V) in mastocytosis. | DisGeNET | Detail |
Ponatinib was found to inhibit the kinase activity of KIT G560V and KIT D816V in the human mast cell... | DisGeNET | Detail |
Two subclones of the HMC1 mast leukaemia cell line were used; both express an identical KIT allele-s... | DisGeNET | Detail |
We expressed c-KIT cDNA constructs encoding the V654A substitution alone and in combination with a t... | DisGeNET | Detail |
Overlapped Transcript Coordinates
Gene | Transcript ID | Exon Number | Chromosome | Start | Stop | Type | Amino Mutation | Transcript Position | Links |
---|
Overlapped Transcript
Gene | Transcript ID | Chromosome | Start | Stop | Links |
---|
- Gene
- -
- dbSNP
- rs121913521 dbSNP
- Genome
- hg19
- Position
- chr4:55,593,613-55,593,613
- Variant Type
- snv
- Reference Allele
- T
- Alternative Allele
- A
- Variant (CIViC) (CIViC Variant)
- V560D
- Transcript 1 (CIViC Variant)
- ENST00000288135.5
- Variant URL (CIViC Variant)
- https://civic.genome.wustl.edu/links/variants/971
Genome browser